1 Vilstrup H, Amodio P, Bajaj J, et al.Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 2014,60:715-735.
2 Rahimi RS, Singal AG, Cuthbert JA,et al.Lactulose vs polyethylene glycol 3350—electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. JAMA Intern Med,2014,174:1727-1733.
3 Cordoba J.New assessment of hepatic encephalopathy. J Hepatol, 2011,54:1030-1040.
4 Bajaj JS, Cordoba J, Mullen KD, et al.Review article: the design of clinical trials in hepatic encephalopathy—an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther,2011,33:739-747.
5 Hammer HF, Santa Ana CA, Schiller LR, et al.Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest,1989,84:1056-1062.
6 Abu Hossain S, Chaudhry FA, Zahedi K, et al.Cellular and molecular basis of increased ammoniagenesis in potassium deprivation. Am J Physiol Renal Physiol,2011,301:F969-F978.
7 Gorkiewicz G, Thallinger GG, Trajanoski S,et al.Alterations in the colonic microbiota in response to osmotic diarrhea. PLoS One,2013,8:e55817.
8 van Berlo CL, van Leeuwen PA, Soeters PB. Porcine intestinal ammonia liberation. Influence of food intake, lactulose and neomycin treatment.J Hepatol,1988,7:250-257. |
